Quarterly Results
RCMT Earnings Forecast
Looking ahead, RCMT remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 84.46M and an EPS of 0.62.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.81%, while EPS estimates have been Revise Downward by -0.22%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 3.13% . These revisions correlate with a -15.86% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in RCMT long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how RCMT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, RCMT sees a +0.16% change in stock price 10 days leading up to the earnings, and a +1.56% change 10 days following the report. On the earnings day itself, the stock moves by +0.16%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2024, the stock changed 4.21% on the day following the earnings release and then changed by -6.55% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of RCMT's latest earnings report for FY2024Q3?
RCMT reported its FY2024Q3 earnings on 2024-11-07, showcasing a revenue of 60.37M against an estimate of 60.45M, resulting in a -0.13% surprise. The EPS was 0.35, surpassing the expected 0.37 by -5.41% . The stock experienced a 0.96% price change on the earnings day and a 3.86% change over the next five days, reflecting market reactions to the results.
How did RCMT's stock price react after the FY2024Q3 earnings release?
Following RCMT's FY2024Q3 earnings announcement on 2024-11-07, the stock price moved by 0.96% on the day of the release. Over the subsequent five days, it saw a 3.86% change. Historically, RCMT's stock price tends to shift by an average of +0.16% in the 10 days leading up to earnings and +1.56% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for RCMT for 2025/Q4?
For 2025/Q4, analysts estimate RCMT’s annual revenue to reach 84.46M, while the EPS is projected at 0.62. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.81% and EPS estimates Revise Upward by 3.13% over the past three months, indicating analyst expectation in the company’s performance.
How does RCMT's stock price correlate with earnings forecast revisions?
The correlation between RCMT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.81%, while EPS estimates moved Revise Upward by 3.13% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from RCMT's next earnings report?
Based on historical trends, RCMT's stock price typically moves by +0.16% in the 10 days before its earnings and +1.56% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.62 and revenue of 84.46M.
What is the sentiment in R C M Technologies Inc (RCMT) Q3 2025 Earnings Call Summary?
The earnings call reveals mixed performance: strong growth in school revenue and engineering gross profit, but declines in non-school revenue and life sciences gross profit. Margins are mixed, with some improvement but also declines. The Q&A highlights uncertainties, like visa issues for foreign candidates and persistent high medical costs. Despite optimistic long-term guidance, immediate concerns and lack of clear execution details temper positive sentiment. Without a market cap, a neutral prediction accounts for these balanced positives and negatives.

